Literature DB >> 5071697

Interactions of benzodiazepines with warfarin.

M Orme, A Breckenridge, R V Brooks.   

Abstract

Administration of nitrazepam (10 mg nightly), diazepam (15 mg/day), and chlordiazepoxide (15 and 30 mg/day) had no effect on steady-state plasma warfarin concentrations, the plasma half-life of warfarin, or anticoagulant control in patients and it appears safe to prescribe these agents to patients on long-term oral anticoagulants. Urinary excretion of 6 beta-hydroxycortisol, however, increased in two out of five patients given chlordiazepoxide. In rats pretreatment with chlordiazepoxide (40 mg/kg for four days) caused stimulation of liver microsomal enzyme activity but neither diazepam nor nitrazepam had this effect.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5071697      PMCID: PMC1785896          DOI: 10.1136/bmj.3.5827.611

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Thrombotest. A new method for controlling anticoagulant therapy.

Authors:  P A OWREN
Journal:  Lancet       Date:  1959-11-07       Impact factor: 79.321

2.  Changes in plasma cortisol induced by dexamphetamine and chlordiazepoxide given alone and in combination in man.

Authors:  P W Butler; G M Besser; H Steinberg
Journal:  J Endocrinol       Date:  1968-03       Impact factor: 4.286

3.  The effect of librium on hemostasis.

Authors:  H Lackner; V E Hunt
Journal:  Am J Med Sci       Date:  1968-12       Impact factor: 2.378

4.  Interaction of commonly prescribed drugs and warfarin.

Authors:  D S Robinson; D Sylwester
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

5.  Clinical implications of enzyme induction.

Authors:  A Breckenridge; M Orme
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

6.  The assay of warfarin in plasma or stool.

Authors:  R J Lewis; L P Ilnicki; M Carlstrom
Journal:  Biochem Med       Date:  1970-12

7.  Induction of liver microsomal cortisol 6beta-hydroxylase by diphenylhydantoin or phenobarbital: an explanation for the increased excretion of 6-hydroxycortisol in humans treated with these drugs.

Authors:  A H Conney; M Jacobson; K Schneidman; R Kuntzman
Journal:  Life Sci       Date:  1965-05       Impact factor: 5.037

8.  Metabolism and tolerance studies with chlordiazepoxide-2-l4C in the rat.

Authors:  D R Hoogland; T S Miya; W F Bousquet
Journal:  Toxicol Appl Pharmacol       Date:  1966-07       Impact factor: 4.219

9.  The effect of some sedatives (phenobarbital, gluthetimide, chlordiazepoxide, chloral hydrate) on the rate of disappearance of ethyl biscoumacetate from the plasma.

Authors:  F E van Dam; M J Gribnau-Overkamp
Journal:  Folia Med Neerl       Date:  1967

10.  Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).

Authors:  A Breckenridge; M L Orme; S Thorgeirsson; D S Davies; R V Brooks
Journal:  Clin Sci       Date:  1971-04       Impact factor: 6.124

  10 in total
  21 in total

1.  Inhibition of drug metabolizing enzymes by diazepam in rat liver.

Authors:  M Vorne; J Idänpään-Heikkilä
Journal:  Experientia       Date:  1975-08-15

Review 2.  Sleep and hypnotic drugs.

Authors:  M W Johns
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  The significance of drug interactions in the evaluation of psychotropic drugs.

Authors:  R A Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

4.  The archaic barbiturate hypnotics.

Authors:  J Koch-Weser; D J Greenblatt
Journal:  Anesth Prog       Date:  1975-03

5.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.

Authors:  P Chopin; M B Assié; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Comparison of the pharmacokinetics of diazepam after single and subchronic doses.

Authors:  U Klotz; K H Antonin; P R Bieck
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

Review 7.  Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

8.  Benzodiazepines and tricyclic antidepressant plasma levels.

Authors:  G Silverman; R A Braithwaite
Journal:  Br Med J       Date:  1973-07-07

Review 9.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 10.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.